The relevance of factor VIII inactivation characteristics in the treatment of patients with antibodies directed against factor VIII

Br J Haematol. 1972 Jun;22(6):735-42. doi: 10.1111/j.1365-2141.1972.tb05718.x.
No abstract available

MeSH terms

  • Animals
  • Antibodies*
  • Antigen-Antibody Reactions
  • Factor VIII*
  • Hemophilia A / complications
  • Hemophilia A / immunology*
  • Hemophilia A / therapy
  • Humans
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Swine
  • Tibial Fractures / complications
  • Time Factors

Substances

  • Antibodies
  • Factor VIII
  • Prednisolone